The price isn’t right

Statins to experience further price disclosure hitA number of the most commonly used medicines are going to experience additional price drops in the newly released October price disclosure cycle.Highly prescribed statins such as atorvastatin (Lipitor) and rosuvastatin (Crestor) are included in this round of reductions.Released on Monday, the October round of cuts will see price